Aline M. Betancourt - Publications

Affiliations: 
Biomedical Sciences Tulane University, New Orleans, LA, United States 
Area:
Cell Biology, Microbiology Biology, Immunology

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Kreisman NR, Wooliscroft LB, Campbell CF, Dotiwala AK, Cox ML, Denson AC, Betancourt AM, Tomchuck SL. Preconditioning Hippocampal Slices with Hypothermia Promotes Rapid Tolerance to Hypoxic Depolarization and Swelling: Mediation by Erythropoietin. Brain Research. 146517. PMID 31634451 DOI: 10.1016/J.Brainres.2019.146517  0.608
2015 Cassano JM, Schnabel LV, Betancourt AM, Antczak DF, Fortier LA. Mesenchymal Stem Cell Therapy: Clinical Progress and Opportunities for Advancement Current Pathobiology Reports. 3: 1-7. DOI: 10.1007/S40139-015-0064-4  0.409
2014 Zhang S, Danchuk SD, Bonvillain RW, Xu B, Scruggs BA, Strong AL, Semon JA, Gimble JM, Betancourt AM, Sullivan DE, Bunnell BA. Interleukin 6 mediates the therapeutic effects of adipose-derived stromal/stem cells in lipopolysaccharide-induced acute lung injury. Stem Cells (Dayton, Ohio). 32: 1616-28. PMID 24449042 DOI: 10.1002/Stem.1632  0.356
2013 Bonvillain RW, Scarritt ME, Pashos NC, Mayeux JP, Meshberger CL, Betancourt AM, Sullivan DE, Bunnell BA. Nonhuman primate lung decellularization and recellularization using a specialized large-organ bioreactor. Journal of Visualized Experiments : Jove. e50825. PMID 24378384 DOI: 10.3791/50825  0.335
2013 Zhang S, Danchuk SD, Imhof KM, Semon JA, Scruggs BA, Bonvillain RW, Strong AL, Gimble JM, Betancourt AM, Sullivan DE, Bunnell BA. Comparison of the therapeutic effects of human and mouse adipose-derived stem cells in a murine model of lipopolysaccharide-induced acute lung injury. Stem Cell Research & Therapy. 4: 13. PMID 23360775 DOI: 10.1186/Scrt161  0.421
2013 Betancourt AM. New Cell-Based Therapy Paradigm: Induction of Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells into Pro-Inflammatory MSC1 and Anti-inflammatory MSC2 Phenotypes. Advances in Biochemical Engineering/Biotechnology. 130: 163-97. PMID 22869086 DOI: 10.1007/10_2012_141  0.45
2012 Waterman RS, Morgenweck J, Nossaman BD, Scandurro AE, Scandurro SA, Betancourt AM. Anti-inflammatory mesenchymal stem cells (MSC2) attenuate symptoms of painful diabetic peripheral neuropathy. Stem Cells Translational Medicine. 1: 557-65. PMID 23197860 DOI: 10.5966/Sctm.2012-0025  0.362
2012 Waterman RS, Henkle SL, Betancourt AM. Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis. Plos One. 7: e45590. PMID 23029122 DOI: 10.1371/Journal.Pone.0045590  0.32
2012 Bonvillain RW, Danchuk S, Sullivan DE, Betancourt AM, Semon JA, Eagle ME, Mayeux JP, Gregory AN, Wang G, Townley IK, Borg ZD, Weiss DJ, Bunnell BA. A nonhuman primate model of lung regeneration: detergent-mediated decellularization and initial in vitro recellularization with mesenchymal stem cells. Tissue Engineering. Part A. 18: 2437-52. PMID 22764775 DOI: 10.1089/Ten.Tea.2011.0594  0.306
2012 Tomchuck SL, Henkle SL, Coffelt SB, Betancourt AM. Toll-like receptor 3 and suppressor of cytokine signaling proteins regulate CXCR4 and CXCR7 expression in bone marrow-derived human multipotent stromal cells. Plos One. 7: e39592. PMID 22745793 DOI: 10.1371/Journal.Pone.0039592  0.654
2012 Tomchuck SL, Henkle SL, Coffelt SB, Betancourt AM. TLR3 stimulation activates a JAK2/STAT1 pathway in hMSC. Plos One. DOI: 10.1371/Journal.Pone.0039592.G001  0.634
2011 Waterman R, Betancourt A. Outside the operating room: unlimited directions in research and beyond. The Ochsner Journal. 11: 14-6. PMID 21603329  0.319
2011 Waterman RS, Betancourt AM. Treating Chronic Pain with Mesenchymal Stem Cells: A Therapeutic Approach Worthy of Continued Investigation Journal of Stem Cell Research & Therapy. 1. DOI: 10.4172/2157-7633.S2-001  0.32
2010 Bunnell BA, Betancourt AM, Sullivan DE. New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell Research & Therapy. 1: 34. PMID 21092149 DOI: 10.1186/Scrt34  0.429
2010 Wu WK, Wang G, Coffelt SB, Betancourt AM, Lee CW, Fan D, Wu K, Yu J, Sung JJ, Cho CH. Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications. International Journal of Cancer. Journal International Du Cancer. 127: 1741-7. PMID 20521250 DOI: 10.1002/Ijc.25489  0.319
2010 Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. Plos One. 5: e10088. PMID 20436665 DOI: 10.1371/Journal.Pone.0010088  0.663
2010 McFerrin H, Angelova M, Abboud E, Nelson A, Betancourt A, Morris G, Shelby B, Morris C, Sullivan D. The angiogenic properties of Kaposi's sarcoma-associated herpesvirus encoded G-protein coupled receptor are reduced by flavopiridol, an inhibitor of cyclin-dependent kinase 9 Infectious Agents and Cancer. 5. DOI: 10.1186/1750-9378-5-S1-A75  0.311
Show low-probability matches.